Back to Search
ANNE DANNENBERG, PH.D.
PH.D.
Student in an Organized Health Care Education/Training Program
NPI: 1740562933Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention.
PMID 15637389·J Clin Oncol·2005
6-review
AGA 2004 distinguished achievement award to Raymond N. Dubois, M.D., Ph.D.
PMID 15188185·Gastroenterology·2004
8-other
Targeting cyclooxygenase-2 in human neoplasia: rationale and promise.
PMID 14706335·Cancer Cell·2003
6-review
Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.
PMID 11905709·Lancet Oncol·2001
6-review
Inhibition of cyclooxygenase-2: an approach to preventing cancer of the upper aerodigestive tract.
PMID 11795429·Ann N Y Acad Sci·2001
6-review
Liquefaction and cavity formation in pulmonary TB: a simple method in rabbit skin to test inhibitors.
PMID 19559651·Tuberculosis (Edinb)·2009
6-review
A model curriculum for a course on the built environment and public health: training for an interdisciplinary workforce.
PMID 19147063·Am J Prev Med·2009
8-other
Bile acids inhibit NAD+-dependent 15-hydroxyprostaglandin dehydrogenase transcription in colonocytes.
PMID 19608733·Am J Physiol Gastrointest Liver Physiol·2009
8-other
Levels of prostaglandin E metabolite and leukotriene E(4) are increased in the urine of smokers: evidence that celecoxib shunts arachidonic acid into the 5-lipoxygenase pathway.
PMID 19336727·Cancer Prev Res (Phila)·2009
3-trial
NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer.
PMID 19138967·Cancer Prev Res (Phila)·2008
7-preclinical
Sulindac derivatives that activate the peroxisome proliferator-activated receptor gamma but lack cyclooxygenase inhibition.
PMID 18665581·J Med Chem·2008
8-other
Combination chemoprevention of HER2/neu-induced breast cancer using a cyclooxygenase-2 inhibitor and a retinoid X receptor-selective retinoid.
PMID 19138958·Cancer Prev Res (Phila)·2008
7-preclinical
Investment in safe routes to school projects: public health benefits for the larger community.
PMID 18558040·Prev Chronic Dis·2008
8-other
Pilot randomized phase II study of celecoxib in oral premalignant lesions.
PMID 18381950·Clin Cancer Res·2008
3-trial
Use of health impact assessment in the U.S.: 27 case studies, 1999-2007.
PMID 18312813·Am J Prev Med·2008
8-other
The built environment, climate change, and health: opportunities for co-benefits.
PMID 18929978·Am J Prev Med·2008
8-other
Effects of tobacco smoke on gene expression and cellular pathways in a cellular model of oral leukoplakia.
PMID 19138943·Cancer Prev Res (Phila)·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2712 TELEGRAPH AVE
BERKELEY, CA 94705 - Phone
- (510) 548-8283
Quick Facts
- NPI
- 1740562933
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile